{"id":31968,"date":"2026-07-21T09:06:36","date_gmt":"2026-07-21T07:06:36","guid":{"rendered":"https:\/\/www.revistanuclear.es\/?p=31968"},"modified":"2026-07-21T09:08:35","modified_gmt":"2026-07-21T07:08:35","slug":"production-of-radioisotopes-for-medical-use","status":"publish","type":"post","link":"https:\/\/www.revistanuclear.es\/en\/more-en\/production-of-radioisotopes-for-medical-use\/","title":{"rendered":"Radioisotopes for medical use and nuclear energy"},"content":{"rendered":"<p style=\"text-align: justify;\"><div class=\"rn-icon-panel__wrap\" style=\"display:flex;justify-content:flex-start;\"><a class=\"rn-icon-panel descargar\" href=\"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Radioisotopos-de-uso-medico-y-nuclear.pdf\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" style=\"--rn-bg:#8baf31;--rn-color:#ffffff;--rn-border:0px solid;--rn-shadow:0px 0px 0px;--rn-rounded:12px;--rn-padding:14px;--rn-gap:10px;--rn-icon-size:30px;\"><span class=\"rn-icon-panel__icon\" aria-hidden=\"true\"><img src=\"https:\/\/revistanuclear.es\/wp-content\/uploads\/2022\/12\/click.png\" alt=\"\" loading=\"lazy\" decoding=\"async\" \/><\/span><span class=\"rn-icon-panel__text\">SEE FULL VERSION<\/span><\/a><br><\/div><span class=\"su-dropcap su-dropcap-style-simple\" style=\"font-size:2.5em\">N<\/span><span style=\"font-weight: 400;\">uclear <strong>fission and fusion<\/strong> energies are antagonistic in nature; however, both can be used to <strong>produce radioisotopes for medical use<\/strong>.<\/span><\/p>\n<h5>Production using nuclear fission energy<\/h5>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Nuclear fission energy is based on a mature technology, and currently, several fission reactors exist worldwide concentrating the majority of the production of some of the most significant radioisotopes of medical interest. Using <strong>molybdenum-99 (<\/strong><\/span><sup><strong>99<\/strong><\/sup><span style=\"font-weight: 400;\"><strong>Mo)<\/strong> as an example, one of the most in-demand radioisotopes, which is used in <strong>86% of SPECT (Single Photon Emission Computed Tomography)<\/strong> diagnostic procedures, totaling approximately 30 million procedures annually all around de world, about<strong> 97% of its production takes place in fission reactors<\/strong>, and the remainder, in cyclotrons.<\/span><\/p>\n<figure id=\"attachment_31977\" aria-describedby=\"caption-attachment-31977\" style=\"width: 444px\" class=\"wp-caption alignright\"><a href=\"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Esquema-MYRRHA.jpg\"><img loading=\"lazy\" decoding=\"async\" loading=\"lazy\" class=\"wp-image-31977\" src=\"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Esquema-MYRRHA.jpg\" alt=\"\" width=\"444\" height=\"456\" srcset=\"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Esquema-MYRRHA.jpg 531w, https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Esquema-MYRRHA-292x300.jpg 292w, https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Esquema-MYRRHA-500x513.jpg 500w, https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Esquema-MYRRHA-293x301.jpg 293w\" sizes=\"auto, (max-width: 444px) 100vw, 444px\" \/><figcaption id=\"caption-attachment-31977\" class=\"wp-caption-text\"><noscript><img fetchpriority=\"high\" decoding=\"async\" class=\"wp-image-31977\" src=\"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Esquema-MYRRHA.jpg\" alt=\"\" width=\"444\" height=\"456\" srcset=\"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Esquema-MYRRHA.jpg 531w, https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Esquema-MYRRHA-292x300.jpg 292w, https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Esquema-MYRRHA-500x513.jpg 500w, https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Esquema-MYRRHA-293x301.jpg 293w\" sizes=\"(max-width: 444px) 100vw, 444px\" \/><\/noscript><\/a> <em>MYRRHA schematic.<\/em><\/figcaption><\/figure>\n<p style=\"text-align: justify;\">The production of this radioisotope is threatened, considering its strong international demand. Therefore, finding new sources of <sup>99<\/sup>Mo production to compensate for its inevitable global shortage, is a priority. The potential deployment of <strong>Small Modular Reactors (SMRs)<\/strong> could be part of that solution. SMRs can produce radioisotopes of medical interest in any of their modalities from both, the GIII+ and GIV reactor generations.<\/p>\n<h5>The potential of fusion energy<\/h5>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Regarding fusion energy, it is based on a simple concept: the joining of two light atomic nuclei that combine to form a heavier nucleus, emitting enormous amounts of energy. However, its production is not simple due to the significant technological challenges involved. Regarding fusion energy, the particle accelerator <strong>International Fusion Materials Irradiation Facility \u2013 Demo Oriented Neutron Source (IFMIF-DONES)<\/strong> is a novel research infrastructure for testing, validating, and qualifying materials that could be used in future fusion power plants.<\/span><\/p>\n<h5 style=\"text-align: justify;\">IFMIF-DONES and medical radioisotopes<\/h5>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">A complementary objective of the IFMIF-DONES infrastructure is the <strong>production of radioisotopes of medical interest<\/strong>. Recent related studies have demonstrated the feasibility of this production method, with a favorable enough cost-benefit ratio to overcome all the technological challenges. These studies have even estimated the potential production of these radioisotopes, including <\/span><strong><sup>99<\/sup><\/strong><span style=\"font-weight: 400;\"><strong>Mo<\/strong>.<\/span><\/p>\n<figure id=\"attachment_31980\" aria-describedby=\"caption-attachment-31980\" style=\"width: 631px\" class=\"wp-caption alignnone\"><a href=\"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Esquema-IFMIF-DONES-1.jpg\"><img loading=\"lazy\" decoding=\"async\" loading=\"lazy\" class=\" wp-image-31980\" src=\"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Esquema-IFMIF-DONES-1.jpg\" alt=\"\" width=\"631\" height=\"310\" srcset=\"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Esquema-IFMIF-DONES-1.jpg 450w, https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Esquema-IFMIF-DONES-1-300x147.jpg 300w, https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Esquema-IFMIF-DONES-1-293x144.jpg 293w\" sizes=\"auto, (max-width: 631px) 100vw, 631px\" \/><figcaption id=\"caption-attachment-31980\" class=\"wp-caption-text\"><noscript><img decoding=\"async\" class=\" wp-image-31980\" src=\"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Esquema-IFMIF-DONES-1.jpg\" alt=\"\" width=\"631\" height=\"310\" srcset=\"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Esquema-IFMIF-DONES-1.jpg 450w, https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Esquema-IFMIF-DONES-1-300x147.jpg 300w, https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Esquema-IFMIF-DONES-1-293x144.jpg 293w\" sizes=\"(max-width: 631px) 100vw, 631px\" \/><\/noscript><\/a> <em>IFMIF-DONES schematic.<\/em><\/figcaption><\/figure>\n<p style=\"text-align: justify;\"><span style=\"font-weight: 400;\">Therefore, everything suggests that <strong>new fission reactors<\/strong>, along with <strong>nuclear fusion energy<\/strong>, could become the solution to complement the current production of radioisotopes for medical use.<\/span><\/p>\n<p class=\"p1\" style=\"text-align: justify;\"><div class=\"rn-icon-panel__wrap\" style=\"display:flex;justify-content:flex-start;\"><a class=\"rn-icon-panel\" href=\"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Radioisotopos-de-uso-medico-y-nuclear.pdf\" target=\"_blank\" rel=\"noopener noreferrer nofollow\" style=\"--rn-bg:#8baf31;--rn-color:#ffffff;--rn-border:0px solid;--rn-shadow:0px 0px 0px;--rn-rounded:12px;--rn-padding:14px;--rn-gap:10px;--rn-icon-size:0px;\"><span class=\"rn-icon-panel__icon\" aria-hidden=\"true\"><img src=\"https:\/\/revistanuclear.es\/wp-content\/uploads\/2022\/12\/click.png\" alt=\"\" loading=\"lazy\" decoding=\"async\" \/><\/span><span class=\"rn-icon-panel__text\">SEE FULL VERSION<\/span><\/a><br><\/div>\n","protected":false},"excerpt":{"rendered":"<p>uclear fission and fusion energies are antagonistic in nature; however, both can be used to produce radioisotopes for medical use. Production using nuclear fission energy Nuclear fission energy is based on a mature technology, and currently, several fission reactors exist worldwide concentrating the majority of the production of some of the most significant radioisotopes of medical interest. Using molybdenum-99 (99Mo) as an example, one of the most in-demand radioisotopes, which is used in 86% of SPECT (Single Photon Emission Computed [&hellip;]<\/p>\n","protected":false},"author":1847,"featured_media":31976,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"mc4wp_mailchimp_campaign":[],"footnotes":""},"categories":[1585,3478],"tags":[1581,4493,707,877,3810,4492],"coauthors":[4501,4497,4506,4510,4513,4515],"class_list":["post-31968","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-more","category-more-en","tag-fision-en","tag-fission","tag-fusion-en","tag-nuclear-energy","tag-radioisotopes","tag-supply"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.7 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Production of radioisotopes for medical use<\/title>\n<meta name=\"description\" content=\"The production of medical radioisotopes can be strengthened through fission reactors, SMRs, and future fusion facilities.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.revistanuclear.es\/en\/more-en\/production-of-radioisotopes-for-medical-use\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Production of radioisotopes for medical use\" \/>\n<meta property=\"og:description\" content=\"The production of medical radioisotopes can be strengthened through fission reactors, SMRs, and future fusion facilities.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.revistanuclear.es\/en\/more-en\/production-of-radioisotopes-for-medical-use\/\" \/>\n<meta property=\"og:site_name\" content=\"Revista Nuclear Espa\u00f1a\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/SNE.spain\" \/>\n<meta property=\"article:published_time\" content=\"2026-07-21T07:06:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2026-07-21T07:08:35+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Radioisotopos-de-uso-medico.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1920\" \/>\n\t<meta property=\"og:image:height\" content=\"1080\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Javier Gallo Carrasco, Noelia Ballesteros, Fernando Mota, Mar\u00eda Isabel Ortiz, Jos\u00e9 Ignacio Porras, Javier Praena\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@SNEu235\" \/>\n<meta name=\"twitter:site\" content=\"@SNEu235\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Javier Gallo Carrasco, Noelia Ballesteros, Fernando Mota, Mar\u00eda Isabel Ortiz, Jos\u00e9 Ignacio Porras, Javier Praena\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/more-en\\\/production-of-radioisotopes-for-medical-use\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/more-en\\\/production-of-radioisotopes-for-medical-use\\\/\"},\"author\":{\"name\":\"Javier Gallo Carrasco\",\"@id\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/#\\\/schema\\\/person\\\/8572534ea56db51969ef2ed299da31f2\"},\"headline\":\"Radioisotopes for medical use and nuclear energy\",\"datePublished\":\"2026-07-21T07:06:36+00:00\",\"dateModified\":\"2026-07-21T07:08:35+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/more-en\\\/production-of-radioisotopes-for-medical-use\\\/\"},\"wordCount\":459,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/more-en\\\/production-of-radioisotopes-for-medical-use\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.revistanuclear.es\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Radioisotopos-de-uso-medico.jpg\",\"keywords\":[\"fision\",\"fission\",\"Fusion\",\"nuclear energy\",\"radioisotopes\",\"supply\"],\"articleSection\":[\"More...\",\"More...\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/more-en\\\/production-of-radioisotopes-for-medical-use\\\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/more-en\\\/production-of-radioisotopes-for-medical-use\\\/\",\"url\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/more-en\\\/production-of-radioisotopes-for-medical-use\\\/\",\"name\":\"Production of radioisotopes for medical use\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/more-en\\\/production-of-radioisotopes-for-medical-use\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/more-en\\\/production-of-radioisotopes-for-medical-use\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.revistanuclear.es\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Radioisotopos-de-uso-medico.jpg\",\"datePublished\":\"2026-07-21T07:06:36+00:00\",\"dateModified\":\"2026-07-21T07:08:35+00:00\",\"description\":\"The production of medical radioisotopes can be strengthened through fission reactors, SMRs, and future fusion facilities.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/more-en\\\/production-of-radioisotopes-for-medical-use\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/more-en\\\/production-of-radioisotopes-for-medical-use\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/more-en\\\/production-of-radioisotopes-for-medical-use\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.revistanuclear.es\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Radioisotopos-de-uso-medico.jpg\",\"contentUrl\":\"https:\\\/\\\/www.revistanuclear.es\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Radioisotopos-de-uso-medico.jpg\",\"width\":1920,\"height\":1080},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/more-en\\\/production-of-radioisotopes-for-medical-use\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Radioisotopes for medical use and nuclear energy\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/\",\"name\":\"Revista Nuclear Espa\u00f1a\",\"description\":\"Revista de los profesionales del sector nuclear en Espa\u00f1a cuya misi\u00f3n es la divulgaci\u00f3n de la ciencia y tecnolog\u00eda nuclear. El objetivo de la Revista es la publicaci\u00f3n de art\u00edculos y contenidos de car\u00e1cter t\u00e9cnico y divulgativo, en diversas \u00e1reas tem\u00e1ticas como son clima y medioambiente, transici\u00f3n energ\u00e9tica, instalaciones nucleares y radiactivas, tecnolog\u00eda nuclear e innovaci\u00f3n, seguridad nuclear y protecci\u00f3n radiol\u00f3gica, ciclo de combustible, residuos radiactivos.\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/#organization\",\"name\":\"SPANISH NUCLEAR SOCIETY\",\"url\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.revistanuclear.es\\\/wp-content\\\/uploads\\\/2019\\\/11\\\/avatar-NE.jpg\",\"contentUrl\":\"https:\\\/\\\/www.revistanuclear.es\\\/wp-content\\\/uploads\\\/2019\\\/11\\\/avatar-NE.jpg\",\"width\":512,\"height\":512,\"caption\":\"SPANISH NUCLEAR SOCIETY\"},\"image\":{\"@id\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/SNE.spain\",\"https:\\\/\\\/x.com\\\/SNEu235\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/#\\\/schema\\\/person\\\/8572534ea56db51969ef2ed299da31f2\",\"name\":\"Javier Gallo Carrasco\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.revistanuclear.es\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Javier-Gallo-1-100x100.jpg42129244bd98ecc2e124f61825c2d45a\",\"url\":\"https:\\\/\\\/www.revistanuclear.es\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Javier-Gallo-1-100x100.jpg\",\"contentUrl\":\"https:\\\/\\\/www.revistanuclear.es\\\/wp-content\\\/uploads\\\/2026\\\/07\\\/Javier-Gallo-1-100x100.jpg\",\"caption\":\"Javier Gallo Carrasco\"},\"description\":\"Project Director EMPRESARIOS AGRUPADOS\",\"url\":\"https:\\\/\\\/www.revistanuclear.es\\\/en\\\/author\\\/javiergg\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Production of radioisotopes for medical use","description":"The production of medical radioisotopes can be strengthened through fission reactors, SMRs, and future fusion facilities.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.revistanuclear.es\/en\/more-en\/production-of-radioisotopes-for-medical-use\/","og_locale":"en_US","og_type":"article","og_title":"Production of radioisotopes for medical use","og_description":"The production of medical radioisotopes can be strengthened through fission reactors, SMRs, and future fusion facilities.","og_url":"https:\/\/www.revistanuclear.es\/en\/more-en\/production-of-radioisotopes-for-medical-use\/","og_site_name":"Revista Nuclear Espa\u00f1a","article_publisher":"https:\/\/www.facebook.com\/SNE.spain","article_published_time":"2026-07-21T07:06:36+00:00","article_modified_time":"2026-07-21T07:08:35+00:00","og_image":[{"width":1920,"height":1080,"url":"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Radioisotopos-de-uso-medico.jpg","type":"image\/jpeg"}],"author":"Javier Gallo Carrasco, Noelia Ballesteros, Fernando Mota, Mar\u00eda Isabel Ortiz, Jos\u00e9 Ignacio Porras, Javier Praena","twitter_card":"summary_large_image","twitter_creator":"@SNEu235","twitter_site":"@SNEu235","twitter_misc":{"Written by":"Javier Gallo Carrasco, Noelia Ballesteros, Fernando Mota, Mar\u00eda Isabel Ortiz, Jos\u00e9 Ignacio Porras, Javier Praena","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.revistanuclear.es\/en\/more-en\/production-of-radioisotopes-for-medical-use\/#article","isPartOf":{"@id":"https:\/\/www.revistanuclear.es\/en\/more-en\/production-of-radioisotopes-for-medical-use\/"},"author":{"name":"Javier Gallo Carrasco","@id":"https:\/\/www.revistanuclear.es\/en\/#\/schema\/person\/8572534ea56db51969ef2ed299da31f2"},"headline":"Radioisotopes for medical use and nuclear energy","datePublished":"2026-07-21T07:06:36+00:00","dateModified":"2026-07-21T07:08:35+00:00","mainEntityOfPage":{"@id":"https:\/\/www.revistanuclear.es\/en\/more-en\/production-of-radioisotopes-for-medical-use\/"},"wordCount":459,"commentCount":0,"publisher":{"@id":"https:\/\/www.revistanuclear.es\/en\/#organization"},"image":{"@id":"https:\/\/www.revistanuclear.es\/en\/more-en\/production-of-radioisotopes-for-medical-use\/#primaryimage"},"thumbnailUrl":"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Radioisotopos-de-uso-medico.jpg","keywords":["fision","fission","Fusion","nuclear energy","radioisotopes","supply"],"articleSection":["More...","More..."],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/www.revistanuclear.es\/en\/more-en\/production-of-radioisotopes-for-medical-use\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/www.revistanuclear.es\/en\/more-en\/production-of-radioisotopes-for-medical-use\/","url":"https:\/\/www.revistanuclear.es\/en\/more-en\/production-of-radioisotopes-for-medical-use\/","name":"Production of radioisotopes for medical use","isPartOf":{"@id":"https:\/\/www.revistanuclear.es\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.revistanuclear.es\/en\/more-en\/production-of-radioisotopes-for-medical-use\/#primaryimage"},"image":{"@id":"https:\/\/www.revistanuclear.es\/en\/more-en\/production-of-radioisotopes-for-medical-use\/#primaryimage"},"thumbnailUrl":"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Radioisotopos-de-uso-medico.jpg","datePublished":"2026-07-21T07:06:36+00:00","dateModified":"2026-07-21T07:08:35+00:00","description":"The production of medical radioisotopes can be strengthened through fission reactors, SMRs, and future fusion facilities.","breadcrumb":{"@id":"https:\/\/www.revistanuclear.es\/en\/more-en\/production-of-radioisotopes-for-medical-use\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.revistanuclear.es\/en\/more-en\/production-of-radioisotopes-for-medical-use\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.revistanuclear.es\/en\/more-en\/production-of-radioisotopes-for-medical-use\/#primaryimage","url":"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Radioisotopos-de-uso-medico.jpg","contentUrl":"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Radioisotopos-de-uso-medico.jpg","width":1920,"height":1080},{"@type":"BreadcrumbList","@id":"https:\/\/www.revistanuclear.es\/en\/more-en\/production-of-radioisotopes-for-medical-use\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.revistanuclear.es\/en\/"},{"@type":"ListItem","position":2,"name":"Radioisotopes for medical use and nuclear energy"}]},{"@type":"WebSite","@id":"https:\/\/www.revistanuclear.es\/en\/#website","url":"https:\/\/www.revistanuclear.es\/en\/","name":"Revista Nuclear Espa\u00f1a","description":"Revista de los profesionales del sector nuclear en Espa\u00f1a cuya misi\u00f3n es la divulgaci\u00f3n de la ciencia y tecnolog\u00eda nuclear. El objetivo de la Revista es la publicaci\u00f3n de art\u00edculos y contenidos de car\u00e1cter t\u00e9cnico y divulgativo, en diversas \u00e1reas tem\u00e1ticas como son clima y medioambiente, transici\u00f3n energ\u00e9tica, instalaciones nucleares y radiactivas, tecnolog\u00eda nuclear e innovaci\u00f3n, seguridad nuclear y protecci\u00f3n radiol\u00f3gica, ciclo de combustible, residuos radiactivos.","publisher":{"@id":"https:\/\/www.revistanuclear.es\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.revistanuclear.es\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.revistanuclear.es\/en\/#organization","name":"SPANISH NUCLEAR SOCIETY","url":"https:\/\/www.revistanuclear.es\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.revistanuclear.es\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2019\/11\/avatar-NE.jpg","contentUrl":"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2019\/11\/avatar-NE.jpg","width":512,"height":512,"caption":"SPANISH NUCLEAR SOCIETY"},"image":{"@id":"https:\/\/www.revistanuclear.es\/en\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/SNE.spain","https:\/\/x.com\/SNEu235"]},{"@type":"Person","@id":"https:\/\/www.revistanuclear.es\/en\/#\/schema\/person\/8572534ea56db51969ef2ed299da31f2","name":"Javier Gallo Carrasco","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Javier-Gallo-1-100x100.jpg42129244bd98ecc2e124f61825c2d45a","url":"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Javier-Gallo-1-100x100.jpg","contentUrl":"https:\/\/www.revistanuclear.es\/wp-content\/uploads\/2026\/07\/Javier-Gallo-1-100x100.jpg","caption":"Javier Gallo Carrasco"},"description":"Project Director EMPRESARIOS AGRUPADOS","url":"https:\/\/www.revistanuclear.es\/en\/author\/javiergg\/"}]}},"_links":{"self":[{"href":"https:\/\/www.revistanuclear.es\/en\/wp-json\/wp\/v2\/posts\/31968","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.revistanuclear.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.revistanuclear.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.revistanuclear.es\/en\/wp-json\/wp\/v2\/users\/1847"}],"replies":[{"embeddable":true,"href":"https:\/\/www.revistanuclear.es\/en\/wp-json\/wp\/v2\/comments?post=31968"}],"version-history":[{"count":7,"href":"https:\/\/www.revistanuclear.es\/en\/wp-json\/wp\/v2\/posts\/31968\/revisions"}],"predecessor-version":[{"id":31997,"href":"https:\/\/www.revistanuclear.es\/en\/wp-json\/wp\/v2\/posts\/31968\/revisions\/31997"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.revistanuclear.es\/en\/wp-json\/wp\/v2\/media\/31976"}],"wp:attachment":[{"href":"https:\/\/www.revistanuclear.es\/en\/wp-json\/wp\/v2\/media?parent=31968"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.revistanuclear.es\/en\/wp-json\/wp\/v2\/categories?post=31968"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.revistanuclear.es\/en\/wp-json\/wp\/v2\/tags?post=31968"},{"taxonomy":"author","embeddable":true,"href":"https:\/\/www.revistanuclear.es\/en\/wp-json\/wp\/v2\/coauthors?post=31968"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}